Methacrylic Acid - Methyl Methacrylate Copolymer (1:2)
Excipient (pharmacologically inactive substance)
Medically reviewed by Drugs.com. Last updated on Sep 14, 2020.
What is it?
Methacrylic acid - methyl methacrylate copolymer (1:2), also known as methacrylic acid copolymer, Type B - NF, is an excipient used in pharmaceutical manufacturing.
It is a solid white powder with dissolution above pH of 7.0, and is used in enteric coatings for fast dissolution in the upper bowel, for granulation of drug substances in powder form for controlled-release, and for site-specific drug delivery. It is typically released in the upper bowel of the gastrointestinal tract.[1]
Top Medications with this excipient
- Asacol 400 mg
- Cartia XT 240 mg
- Cartia XT 120 mg
- Dexilant 60 mg
- Diltiazem Hydrochloride Extended-Release 420 mg
- Diltiazem Hydrochloride Extended-Release 300 mg
- Diltiazem Hydrochloride Extended-Release (CD) 240 mg
- Diltiazem Hydrochloride Extended-Release (SR) 90 mg
- Glipizide Extended Release 10 mg
- Glipizide Extended-Release 10 mg
- Lamotrigine Extended-Release 300 mg
- Mesalamine delayed-release 800 mg
- Metoprolol Succinate Extended-Release 25 mg
- Metoprolol Succinate Extended-Release 50 mg
- Metoprolol Succinate Extended-Release 100 mg
- Omeprazole Magnesium Delayed-Release 20 mg (base)
- Sular 17 mg
- Sular 34 mg
- Verapamil Hydrochloride Extended Release 300 mg
- Videx EC 200 MG
References
[1] Evonik Industries. Eudragit. Eudragit S 100. Description. Accessed 8/15/2012. http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/s-100/pages/default.aspx
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.